SFDA set to approve two H1N1 vaccines
In the next week the Chinese SFDA is expected to approve licences for two locally produced H1N1 vaccines, which unlike some alternatives only require one dose to confer immunity.
Archives for September 1, 2009
Genzyme receives EMEA letter about Allston plant
The EMEA has issued US biotech firm Genzyme with a letter detailing “one major observation and several other observations” following an inspection of its Allston, Massachusetts manufacturing plant last month.
Californian budget deficit poses “real risk” to biotech investment
The Californian budget deficit presents a “real risk to future biotech investments”, according to the CEO of BayBio who explained to how the industry now has a difficult relationship with the state.
Synexus brings high recruitment rate methods to new sites in Poland
Synexus is meeting the rising demand for its services, which it says can dramatically increase recruitment rates, by acquiring clinical trial sites in Poland and is hoping to expand in India soon.
Summit sells Dextra services division
Summit has sold Dextra, its analytical and manufacturing services division, to NZP but believes operating the contract business has been beneficial to its industry standing and R&D capabilities.
PerkinElmer’s radiosynthesis plant to meet demand for ADME
US firm PerkinElmer has opened a second plant to meet growing demand for radiolablled compounds for ADME and, it hopes, ultimately help drugmakers make go/no go development decisions earlier.